Cleerly ISCHEMIA vs Steth IO
AI Verdict
Choose Cleerly ISCHEMIA if…
Choose Cleerly ISCHEMIA if you require a sophisticated, non-invasive AI-powered analysis of CCTA scans to precisely determine the likelihood of coronary artery ischemia at a vessel level. This tool is ideal for detailed diagnostic assessment, including coronary plaque characterization and stenosis severity, to inform personalized treatment planning for heart disease. It provides comprehensive anatomical and functional insights for complex cardiology cases.
View Cleerly ISCHEMIA →Choose Steth IO if…
Choose Steth IO if you need a portable, real-time solution for auscultation, remote patient monitoring, and telemedicine consultations. This smartphone-powered stethoscope is perfect for healthcare providers who need to hear, visualize, record, and securely share heart and lung sounds instantly, enhancing diagnostic accuracy in both in-person and virtual care settings. It streamlines initial assessments and ongoing management of cardiac and pulmonary conditions.
View Steth IO →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly ISCHEMIA | Steth IO |
|---|---|---|
| Pricing | Unknown | Customized pricing; subscription-based for steth io spot. |
| Deployment | Web-based solution | Cloud-based |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Steth IOSteth IO offers a smartphone-powered stethoscope with a mobile app, making it highly portable and accessible for various healthcare providers in diverse settings, including telemedicine and remote monitoring. Cleerly ISCHEMIA, while powerful, is a web-based platform for CCTA analysis, requiring specific imaging infrastructure and integration into a specialized workflow.
Clinical Value
Cleerly ISCHEMIACleerly ISCHEMIA provides a highly specialized and advanced diagnostic capability for coronary artery disease by analyzing CCTA scans for non-invasive FFR estimation and detailed plaque characterization, offering precise insights for personalized diagnosis and treatment planning. Steth IO enhances a traditional diagnostic tool (stethoscope) with digital features, improving accessibility and sharing, but Cleerly's impact on complex cardiac diagnosis is more profound.
Pricing & Value
Steth IOSteth IO provides some public pricing transparency with its annual membership for Steth IO Spot at $15/month, allowing for an initial assessment of its value. Cleerly ISCHEMIA's pricing is not publicly disclosed, requiring direct contact for details, which makes it challenging for potential users to evaluate its cost-effectiveness upfront.
Enterprise Readiness
Cleerly ISCHEMIACleerly ISCHEMIA explicitly states it is HIPAA compliant and offers a Business Associate Agreement (BAA), which are critical for enterprise adoption in healthcare, along with web-based deployment and API integration. Steth IO indicates the user is responsible for HIPAA compliance and includes a warning for email export, suggesting a less robust enterprise-level compliance framework.
Innovation
Cleerly ISCHEMIACleerly ISCHEMIA leverages advanced AI to provide novel diagnostic insights from CCTA scans, including non-invasive fractional flow reserve (FFR) estimation and detailed coronary plaque characterization, representing a significant advancement in non-invasive cardiac diagnostics. Steth IO innovates by digitizing and mobilizing the traditional stethoscope, which is valuable for accessibility and sharing, but less groundbreaking in terms of novel diagnostic capabilities.
Support & Docs
Cleerly ISCHEMIACleerly offers dedicated 'Client Support' with specified operating hours and a clear contact method for existing users, alongside a comprehensive suite of educational resources like publications, webinars, and FAQs. Steth IO provides a user guide and an email for support, but Cleerly's more structured support system and broader resource availability suggest a more robust support ecosystem.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly ISCHEMIA | Steth IO |
|---|---|---|
| Tool Name | Cleerly ISCHEMIA | Steth IO |
| Company | Cleerly | STRATOSCIENTIFIC |
| Primary Function/Modality | FDA-cleared AI tool analyzing CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level. | FDA-cleared smartphone stethoscope that transforms a mobile device into a diagnostic aid for hearing, visualizing, recording, and sharing heart and lung sounds. |
| Key Analytical Capability | AI-enabled CCTA analysis, non-invasive fractional flow reserve (FFR) estimation, vessel-level ischemia likelihood determination, coronary plaque characterization, stenosis severity assessment. | Real-time visualization of heart and lung sounds (phonocardiogram/spectrogram), digital filters for sound enhancement and ambient noise attenuation. |
| Data Sharing/Integration | Integration with PowerScribe via API, comprehensive interactive web-based reports. | Share exams with specialists/other healthcare providers, telemedicine capabilities (live auscultation, video calls, scheduling), remote patient monitoring. |
| Target Specialties | Cardiology, Radiology | Cardiology, Internal Medicine, Pulmonology |
Videos
Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and Steth IO.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly ISCHEMIA or Steth IO
Backers
Who funded each tool's parent company.